Streetbeat News

Earnings

DLB

Dolby Laboratories (NYSE:DLB) reported Q1 adjusted EPS of $1.01, surpassing the $0.86 estimate, and sales of $315.57M, exceeding the $312.87M estimate. However, this represents a 9.01% decrease in earnings and a 5.78% decrease in sales from the same period last year.

Portfolio Pulse from totan@benzinga.com

February 01, 2024 | 9:16 pm

GEN

Gen forecasts its FY24 adjusted EPS to be between $1.95 and $1.97, below the $2.27 estimate. Revenue is expected to be between $3.805B and $3.815B, also below the $3.988B estimate.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 9:15 pm

OTEX

Open Text (NASDAQ:OTEX) reported Q2 earnings with an EPS of $1.24, beating estimates by 4.2% against an expected $1.19. Revenue increased to $637.56 million from the previous year. The company has a history of surpassing EPS estimates, as seen in the last quarter with an 11 cent beat and a subsequent 5.34% share price increase the following day. This pattern of outperforming earnings expectations suggests a positive trend in Open Text's financial performance.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:15 pm

CLX

Clorox reported Q2 2024 adjusted EPS of $2.16, surpassing the $1.10 estimate, with sales of $1.99B also beating the $1.80B estimate. This represents a 16.03% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 9:15 pm

EXPO

Exponent (NASDAQ:EXPO) reported Q4 earnings with an EPS of $0.41, missing estimates by 6.82% and a revenue decrease of $4.46 million from the previous year. This follows a pattern of missed EPS estimates in previous quarters, notably leading to a 14.37% share price drop after last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:15 pm

OTEX

Open Text (NASDAQ:OTEX) reported Q2 earnings with an EPS of $1.24, beating estimates by 4.2% against an expected $1.19. Revenue increased to $637.56 million from the same period last year. The company has a history of surpassing EPS estimates, which previously led to a 5.34% share price increase the day after last quarter's earnings announcement.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:15 pm

SKYW

SkyWest (NASDAQ:SKYW) reported Q4 earnings with an EPS of $0.42, beating estimates by 180% and showing a significant revenue increase of $70.54 million from the previous year. This follows a pattern of beating EPS estimates in previous quarters, with a notable share price increase of 11.62% after last quarter's earnings beat.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:15 pm

HOLX

Hologic (NASDAQ:HOLX) reported Q1 earnings with an EPS of $0.98, beating the estimate of $0.95 by 3.16%. However, revenue decreased by $61.00 million compared to the same period last year. In the previous quarter, Hologic's EPS beat estimates by $0.05, leading to a 7.34% share price increase the next day. The company has shown a pattern of surpassing EPS estimates over the past quarters.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:15 pm

SKX

Skechers USA (NYSE:SKX) reported Q4 earnings, beating estimated earnings by 3.7% with an EPS of $0.56 versus an estimate of $0.54. Revenue increased by $82.00 million from the same period last year. Despite beating EPS estimates in the past, such as last quarter's beat by $0.14, the share price dropped by 1.45% the next day.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:15 pm

CLX

Clorox (NYSE:CLX) reported Q2 earnings with a significant beat on estimated earnings by 96.36%, posting an EPS of $2.16 against an estimate of $1.1. Revenue increased by $275 million from the same period last year. This follows a pattern of beating EPS estimates in previous quarters, with the last quarter's beat followed by a 6.61% share price increase the next day.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 9:15 pm